BioLineRx : Annual Report on Form 20-F FOR 2023 -March 26, 2024 at 08:40 am EDT

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 20-F




...

Related Keywords

United States ,Washington ,Israel ,Modiin ,Israel General ,American ,Israeli ,Philipa Serlin , ,Company American Depositary ,Biolinerx Ltd ,Israel Companies Law ,International Accounting Standards Board ,International Financial Reporting Standards ,Company Contact Person ,Securities Exchange ,Exchange Commission ,Companies Law ,Mark One ,Securities Exchange Act ,Ma Ayan Street Modi In ,Depositary Shares ,American Depositary ,Interactive Data File ,Regulations T ,Financial Accounting Standards Board ,Accounting Standards Codification ,Sarbanes Oxley Act ,Financial Reporting Standards ,Exchange Act ,Annual Report ,American Depositary Shares ,United States Dollars ,New Israeli Shekels ,Financial Review ,Financial Condition ,Ordinary Shares ,License Agreement ,Loan Agreement ,Kreos Capital ,